The key ingredient to effective cancer treatments
About 50 percent of cancer patients have tumors that are resistant to radiation because of low levels of oxygen—a state known as hypoxia. A startup in San Francisco is developing proteins that could carry oxygen to tumors more effectively, increasing the odds that radiation therapy will help these patients.
Last month, the National Cancer Institute (NCI) gave that startup, Omniox, $3 million in funding. Omniox is collaborating with researchers at the NCI to test whether its oxygen-carrying compounds improve radiation therapy in animals with cancer.
- CMS to Speak with ICD-10 Backers Tuesday
- Boston Marathon Bombing Yields Lessons for Hospitals
- Governor Details Healthcare Payment Reform Path in Arkansas
- Feds Stonewall ICD-10 Summit
- Hospital Groups Back NQF Report on Patient Sociodemographics
- Physician Payment Data is Where the Action Is
- Reform Puts Vise Grips on Physicians
- MetroHealth Revs Its Population Health Engine
- Medicare Opt-Out a Viable Physician Strategy
- HIX Success Could Generate Add-On Revenue for CT